View Author
vaccination virus cancer influenza response patient antibody fluenza breast vaccine titer study person chemotherapy infection group fi rst-line chemotherapy pandemic breast cancer brca 1 fluenza virus vaccination metastatic breast cancer survival history breast cancer patients metastatic fluenza virus vaccine table mutation disease carrier antibody response signi influenza vaccination therapy influenza viruses oncology antigen brca 2-mutation carriers fi rst vaccination metastatic disease oncology information downloaded month hi titer signi ficantly vaccinated immunity baseline netherland progression-free american society brca 1- progression-free survival erasmu society rst-line ficant adjuvant assay sample american h 1n 2009 difference effect serum strain point treatment vaccination group erasmus mc medische bibliotheek sensitivity brca 1-associated patients regimen result microarray antibody titers tumor 7 months profile
3 Most Recent Publications
|
Profiling of Humoral Response to Influenza A(H1N1)pdm09 Infection and Vaccination Measured by a Protein Microarray in Persons with and without History of Seasonal Vaccination
(Article)
Huijskens, E. Reimerink, J.H.J. Rossen, J.W. Koopmans, M.P.G. Mulder, P.G.H. Beek, J.J. van Meijer, A.C. Bruin, E. de Friesema, I.H.M. Jong, M.D. de Rimmelzwaan, G.F. Peeters, M. |
2013-01-30
|
|
Immunogenicity, boostability, and sustainability of the immune response after vaccination against influenza A virus (H1N1) 2009 in a healthy population
(Article)
Huijskens, E. Rossen, J. Mulder, P. Beek, R. van Vugt, H. van Verbakel, J. Rimmelzwaan, G.F. Koopmans, M. Peeters, M. |
2011-09-01
|
|
Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers
(Article)
Kriege, M. Seynaeve, C.M. Ouweland, A.M.W. van den Geel, B.N. van Hooning, M. Brekelmans, C.T. Klijn, J.G.M. Meijers-Heijboer, H. Collee, J.M. Menke-Pluymers, M.B.E. Bartels, C.C.M. Tilanus-Linthorst, M.M.A. Blom, J. Huijskens, E. Jager, A. |
2009-08-10
|
